This is a case report on using rFVIIa to control severe bleeding following orthotopic cardiac transplant with multiple previous cardiac surgeries. Bleeding was initially uncontrolled despite the use of continuous aprotinin infusion and massive blood component therapy. Bleeding slowed dramatically after administration of one dose of rFVIIa at a dose of 90 mcg/kg. Treatment was not complicated by occurrence of coagulopathy.
>br>
– Maadh Aldouri
NATA: Network for the advancement of Patient Blood Manegement, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther heathcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.